| Identification | Back Directory | [Name]
Momordicoside G | [CAS]
81371-54-2 | [Synonyms]
Momordicoside G
Momordicacoside G
Momordica charantia saponin G
β-D-Allopyranoside, (3S,5R,8S,9S,10S,13R,14S,17R)-1,3,4,8,10,11,12,13,14,15,16,17-dodecahydro-17-[(1R,3E)-5-methoxy-1,5-dimethyl-3-hexenyl]-4,4,13,14-tetramethyl-5,9-(epoxymethano)-2H-cyclopenta[a]phenanthren-3-yl | [EINECS(EC#)]
200-258-5 | [Molecular Formula]
C37H60O8 | [MDL Number]
MFCD20260922 | [MOL File]
81371-54-2.mol | [Molecular Weight]
632.88 |
| Hazard Information | Back Directory | [Uses]
Momordicoside G can be used to regulate macrophage phenotypes to stimulate lung injury repair, as well as, prevent urethane-induced lung carcinoma lesions. It can also be used for anti-diabetic and anti-inflammatory effects. | [Definition]
ChEBI: Momordicoside G is a glycoside and a cucurbitacin. |
|
| Company Name: |
BioBioPha Co., Ltd.
|
| Tel: |
0871-65217109 13211707573; |
| Website: |
http://www.biobiopha.com |
|